Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients
- 25 May 2007
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 81 (4), 280-287
- https://doi.org/10.1016/j.lfs.2007.05.012
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell LinesMolecular Endocrinology, 2007
- Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patientsLife Sciences, 2007
- Gene promoter hypermethylation in ductal lavage fluid from healthy BRCAgene mutation carriers and mutation-negative controlsBreast Cancer Research, 2007
- Hypermethylation of theBreast Cancer–Associated Gene 1Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2007
- Restoration of Tamoxifen Sensitivity in Estrogen Receptor–Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor ComplexesCancer Research, 2006
- Detection of RASSF1A and RAR? Hypermethylation in Serum DNA from Breast Cancer PatientsEpigenetics, 2006
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Hereditary breast cancer: a reviewSeminars in Cancer Biology, 2000
- Distinct transcription start sites generate two forms of BRCA1 mRNAHuman Molecular Genetics, 1995